Dutch Immunologic (WellMed B.V.) – DAKEWE BIOTECH CO. LTD.

Date: September 2025 Client: WellMed B.V. Sector: Healthcare Service: Partnering advisory Definitive agreement with Dutch Immunologic (WellMed B.V.) and DAKEWE BIOTECH CO. LTD. Arnhem, Shenzhen, September 4th, 2025. Orange Corporate Finance acted as exclusive financial advisor to Dutch Immunologic (WellMed B.V.) to reach the next step in partnering with DAKEWE. About Immunologic Immunologic (WellMed B.V.)…

Zorgassist – Miep

Date: April 2023 Client: Zorgassist Sector: Healthcare Service: Sell-side advisory Miep acquires Zorgassist As of 1 April 2023, Miep Huishoudservice en begeleiding, headquartered in Zierikzee, has acquired the household support activities of Zorgassist. Miep and Zorgassist provide household support to clients at home in the Netherlands. Both organisations have already worked together and fit well…

Basic Pharma – Ace Compounding

Date: February 2022 Client: Basic Pharma Sector: Pharmaceutical Service: Sell-side advisory Basic Pharma sells its stake in Geleen-based Pharmalot Compounding As of 24 February 2022 Basic Pharma sold its 50% stake in Pharmalot Compounding to Ace Compounding, a subsidiary of the Zeewolde-based company Ace Holding. This merger will make Ace Holding a larger and stronger…

Home Instead Thuisservice

Date: September 2018 Client: Home Instead Thuisservice BV Sector: Healthcare, Franchise Service: Buy-side advisory, Valuation Home Instead Thuisservice buy-out of minority shareholders Orange Corporate Finance assisted the majority shareholder in Home Instead Thuisservice in the buy-out of the minority shareholders. To substantiate the value of the company, Orange Corporate Finance prepared a comprehensive valuation report.…